Cadila Healthcare informs about press release

13 Mar 2019 Evaluate

Cadila Healthcare has informed about submission of a copy of press release dated March 13, 2019 titled ‘Zydus receives final approval from the USFDA for Potassium Chloride Extended-Release Capsules USP’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

926.10 -5.35 (-0.57%)
08-Dec-2025 13:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1269.40
Cipla 1507.10
Zydus Lifesciences 926.10
Lupin 2070.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×